Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
With a medicine on the market and plenty of projects in the pipeline, this company's trajectory could be very positive for investors without being a smooth ride.
Overview
Technically sophisticated gene-editing biotechs like CRISPR Therapeutics (NASDAQ: CRSP) could become dramatically more capable over the next 10 years if their most ambitious plans come to fruition. If that happens, it'd likely make those who invest today much wealthier.
But where exactly will CRISPR Therapeutics be in 2036, given what it's doing today and what it wants to do tomorrow?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.